NUTXNutex Health Inc.
$206.30+115% 1Y
$206.30
$87.0152 weeks$225.00
The financials
Nutex Health Inc. by the numbers
Nutex Health Inc. (NUTX) reported revenue of $211M in Q2 2026 (quarter ended Jun 30, 2026), down 14% from the same quarter a year earlier. That came with a gross margin of 67% and net income of $66M (31% of revenue). For the full year FY2025, revenue was $875M (+82% year on year) and net income $71M. Its largest product in Q2 2026 was Hospital Division at $202M, 96% of the disclosed total, well ahead of Population Health Management Division at 4.2%. The next results filing is expected around Nov 17, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $211M | $244M | −14% |
| Gross profit | $141M | $125M | +13% |
| Operating income | $122M | $34M | +261% |
| Net income | $66M | −$18M | to a profit |
| Diluted EPS | $9.38 | −$2.95 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Hospital Division | $202M | 96% |
| Population Health Management Division | $8.9M | 4.2% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $210.8M (-2.6%)
Population Health Management Division grew +16% year on yearHospital Division -15% year on year
Segment Latestquarter on quarteryear on year
- Hospital Division$201.9M$201.9Mquarter on quarter -2.8%year on year -15%-2.8%-15%
- Population Health Management Division$8.9M$8.9Mquarter on quarter -0.17%year on year +16%-0.17%+16%